Time to include young adults in Type 2 Diabetes Cardiovascular Outcomes trials
Cardiovascular outcome trials have brought remarkable clinical innovation in Type 2 Diabetes management. However, clinical management of a high-risk population, the young adults with young-onset Type 2 Diabetes, has been excluded from most of these trials. Since Type 2 diabetes has rising incidence rates towards younger ages, the article “Cardiovascular Outcomes Trials in Type 2 Diabetes: Time to Include Young Adults” calls for improvement by including more young adults with young-onset Type 2 Diabetes in these trials so as to better understand diabetes medication effectiveness in this population. (Diabetes Obes Metab. 2019 Sep 4. doi: 10.1111/dom.13874. [Epub ahead of print])
Anyone interested in future collaboration in this field of research is welcome to contact our key investigator Prof Juliana Chan in Department of Medicine and Therapeutics, CUHK. She is the director of Clinical Research Management Office and the Hong Kong Institute of Diabetes and Obesity. Prof Chan’s research focuses on epidemiology, genetics, clinical trials and care models of diabetes and obesity.
Read the full article: https://onlinelibrary.wiley.com/doi/epdf/10.1111/dom.13874
More about research at CU Medicine: https://www.med.cuhk.edu.hk/research
